Trifluridine and Tipiracil Hydrochloride Tablets

Trifluridine Tipipiracil Tablets are mainly suitable for patients with metastatic colorectal cancer (mCRC) who have previously received chemotherapy based on fluoropyrimidines, oxaliplatin and irinotecan, and who have previously received or are not suitable for anti-vascular endothelial growth factor (VEGF) treatment and anti-epidermal growth factor receptor (EGFR) treatment (RAS wild type).
Trifluridine Tipipiracil Tablets can inhibit the synthesis of DNA and RNA of tumor cells, prevent the proliferation and spread of tumor cells, and treat diseases such as metastatic colorectal cancer and metastatic gastric cancer;